Skip to search
Skip to main content
Catalog
Help
Feedback
Your Account
Library Account
Bookmarks
(
0
)
Search History
Search in
Keyword
Title (keyword)
Author (keyword)
Subject (keyword)
Title starts with
Subject (browse)
Author (browse)
Author (sorted by title)
Call number (browse)
search for
Search
Advanced Search
Bookmarks
(
0
)
Princeton University Library Catalog
Start over
Send
to
SMS
Email
Printer
Bookmark
Strategies Toward Inhibition of the Polycomb Repressive Complex 2 Using PNA Conjugates and Bitopic Peptides
Author/Artist
Kong, Ha Eun
[Browse]
Format
Senior thesis
Language
English
Description
86 pages
Availability
Available Online
Citation only:
DataSpace
Copies in the Library
Location
Call Number
Status
Location Service
Notes
Mudd Manuscript Library - Stacks
AC102
Browse related items
On-site access
Reading Room Request
Details
Advisor(s)
Muir, Thomas
[Browse]
Department
Princeton University. Department of Chemistry
[Browse]
Class year
2013
Restrictions note
Walk-in Access. This thesis can only be viewed on computer terminals at the
Mudd Manuscript Library
.
Summary note
H3K27M is a mutation in the H3 histone tail of nucleosomes that is implicated in diffuse intrinsic pontine glioma (DIPG), a fatal tumor in the brainstem that is prevalent among children. The H3K27M mutation inhibits EZH2, the catalytic domain of PRC2, a histone methyltransferase enzyme complex, which results in the reduction of global H3K27me3 levels. Potent peptide-based synthetic inhibitors of PRC2 would serve as useful probes to elucidate the mechanism of PRC2 inhibition by K27M, and would promote the development of potential therapeutics for adult pathologies characterized by hyperactivity of the EZH2 subunit. However, to date, potent inhibitors targeting the PRC2 have not been developed. In this study, two different strategies were used to evaluate PRC2 inhibition. PNA’s (Peptide Nucleic Acids) served to direct PNA-bound H3K27M peptide to the nucleosome, thereby recruiting PRC2 to the nucleosome for potentially multivalent inhibition. Also, bitopic peptides containing binding sites to two domains of PRC2, the EZH2 and RbAp46/48 domains, were synthesized with linkers of varied lengths in order to investigate the effects of bivalent binding in PRC2 inhibition. While the PNA-H3\(_{23-34}\) K27M did not inhibit PRC2 under the specific assay conditions, the bitopic peptides H3\(_{1-10}\)-(PEG)\(_{n}\)-H3\(_{21-37}\) K27Nle (n=1,2,3) showed stronger inhibition than the H3\(_{1-10}\) and H3\(_{21-37}\) K27Nle peptides in trans, demonstrating that the presence of two binding domains in the peptides confers increased potency of inhibition. The shortest bitopic peptide exhibited the strongest inhibition in the series, illuminating geometric preferences of bivalent binding. This study highlights the significance of bitopicity in enhancing inhibition of multivalent complexes such as PRC2, which could lead to the development of the next generation of potent PRC2 inhibitors for cancer therapy.
Statement on language in description
Princeton University Library aims to describe library materials in a manner that is respectful to the individuals and communities who create, use, and are represented in the collections we manage.
Read more...
Ask a Question
Suggest a Correction
Report Harmful Language
Supplementary Information